The Nuclease Activity of the Yeast Dna2 Protein, Which Is Related to the RecB-like Nucleases, Is Essential in Vivo by Budd, Martin E. et al.
The Nuclease Activity of the Yeast Dna2 Protein, Which Is Related
to the RecB-like Nucleases, Is Essential in Vivo*
Received for publication, November 24, 1999, and in revised form, March 3, 2000
Published, JBC Papers in Press, March 23, 2000, DOI 10.1074/jbc.M909511199
Martin E. Budd, Won-chae Choe, and Judith L. Campbell‡
From the Braun Laboratory, California Institute of Technology, Pasadena, California 91125
Saccharomyces cerevisiae Dna2 protein is required for
DNA replication and repair and is associated with mul-
tiple biochemical activities: DNA-dependent ATPase,
DNA helicase, and DNA nuclease. To investigate which
of these activities is important for the cellular functions
of Dna2, we have identified separation of function mu-
tations that selectively inactivate the helicase or nucle-
ase. We describe the effect of six such mutations on
ATPase, helicase, and nuclease after purification of the
mutant proteins from yeast or baculovirus-infected in-
sect cells. A mutation in the Walker A box in the C-
terminal third of the protein affects helicase and
ATPase but not nuclease; a mutation in the N-terminal
domain (amino acid 504) affects ATPase, helicase, and
nuclease. Two mutations in the N-terminal domain abol-
ish nuclease but do not reduce helicase activity (amino
acids 657 and 675) and identify the putative nuclease
active site. Two mutations immediately adjacent to the
proposed nuclease active site (amino acids 640 and 693)
impair nuclease activity in the absence of ATP but com-
pletely abolish nuclease activity in the presence of ATP.
These results suggest that, although the Dna2 helicase
and nuclease activities can be independently affected by
some mutations, the two activities appear to interact,
and the nuclease activity is regulated in a complex man-
ner by ATP. Physiological analysis shows that both
ATPase and nuclease are important for the essential
function of DNA2 in DNA replication and for its role in
double-strand break repair. Four of the nuclease mu-
tants are not only loss of function mutations but also
exhibit a dominant negative phenotype.
Yeast dna2–1 mutants were originally identified in a screen
for mutants defective in DNA replication in vitro (1) and were
then shown to be defective in DNA replication in vivo (1, 2).
Since that time, additional dna2 mutants with similar pheno-
types have been identified and characterized (3, 4). Fluores-
cence-activated cell sorting analysis shows that temperature-
sensitive dna2 mutants can synthesize a full 2C DNA content
at 37 °C (3).1 The DNA synthesized is highly fragmented, how-
ever, indicating that, although there is extensive DNA synthe-
sis, DNA replication is incomplete in some way (2). Strains
with dna2 deletions are inviable, showing Dna2 performs an
essential function during DNA replication (2–4). Recently, it
has also been demonstrated that dna2 mutants are defective in
repair of x-ray-, bleomycin-, and methylmethane sulfonate-
induced DNA damage (4, 5).
Dna2 is a 170-kDa protein with six motifs characteristic of
DNA helicases in the C-terminal third of the protein. A sche-
matic diagram of the protein is shown in Fig. 1. Genes homol-
ogous to DNA2 have been identified in Schizosaccharomyces
pombe, Xenopus laevis, Caenorhabditis elegans, and humans
(6–8). Immunoaffinity-purified Dna2 has DNA-dependent
ATPase activity, DNA helicase activity that requires a 59 non-
hybridized tail adjacent to the duplex region unwound, and a
potent endonuclease activity (2, 9–11). The helicase and
ATPase activities are required for the essential function of
Dna2 since mutation of the ATP binding motif (K1080E) abol-
ishes both ATPase and helicase and results in a gene that does
not complement either a dna2–1 or a dna2D mutant (9). Other
dna2 mutations that reduce but do not abolish ATP binding
and/or hydrolysis support growth under some conditions, show-
ing that the full helicase activity is not essential for viability,
and leading to the suggestion that it is the nuclease activity
that is essential (4). A recent analysis suggests that Dna2 falls
into the RecB class of helicase/nuclease proteins, with homol-
ogy to the nuclease localized to a short motif in the N-terminal
half of the protein, corresponding to the putative active site of
RecB nuclease (see Fig. 1).
Preliminary characterization of the nuclease activity associ-
ated with immunoaffinity-purified Dna2 suggested that it was
a so-called structure-specific nuclease, in that it removed 59
single-stranded tails adjacent to a duplex region, but not 39
single-stranded tails and did not digest duplex DNA (10). This
suggested to us that Dna2 might have an intrinsic nuclease
and/or that it might copurify with yeast flap endonuclease-1
(FEN-1), which has similar substrate specificity (12, 13). Sur-
prisingly, both interpretations appear to be correct. FEN-1 is a
59 to 39 exonuclease that also functions as an endonuclease on
a 59 single-stranded flap structure adjacent to a duplex region,
cutting at (or near, depending on the context) the junction
between the single- and double-stranded region. The human
FEN-1 homologue participates in the maturation of Okazaki
fragments synthesized during an in vitro SV-40 DNA replica-
tion reaction (14–16). Yeast FEN-1 is encoded by the RAD27
gene (17, 18), and the phenotype of rad27D mutants suggests,
albeit indirectly, that the mutants are defective in Okazaki
fragment maturation. For instance, rad27D mutants are viable
at 23 °C but not at 37 °C, cause a high level of mutagenesis, but
are not defective in repair (17, 18). rad27D mutants show an
increased frequency of duplications at repeated structures,
which might occur due to faulty Okazaki fragment processing
(19). rad27D mutants accumulate expansions of di- and tri-
nucleotide repeat DNA tracts, which could be explained by
fold-back of FLAP structures on Okazaki fragments at stalled
replication forks (17, 20, 21). We have documented strong ge-
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netic interactions between DNA2 and RAD27. Overexpression
of RAD27 complements dna2–1 strains and overproduction of
DNA2 suppresses the temperature-sensitive growth defect of
rad27D strains. rad27D dna2–1 strains are inviable. Biochem-
ical studies showed that the affinity-purified Dna2 prepara-
tions contained FEN-1 and that FEN-1 and Dna2 co-immuno-
precipitated from yeast extracts. This genetic and biochemical
evidence led us to propose that Dna2, like FEN-1, functions in
Okazaki fragment maturation (10), but left the mechanism ill
defined. Dna2 could either substitute for FEN-1, or assist
FEN-1 in its function, or repair errors made by FEN-1. Over-
expression of RAD27 also suppresses this sensitivity of dna2
mutants to x-rays (5), suggesting again an interaction or func-
tional overlap between the two, although rad27D strains are
proficient in DSB2 repair (17).
We next purified Dna2 from a rad27D strain, and we found
that a potent nuclease activity was still present, suggesting
that, in addition to associating with FEN-1, DNA2 encodes an
integral nuclease (10). That Dna2 is itself a nuclease was
strongly supported by more extensive characterization of a
nuclease associated with recombinant yeast Dna2 protein pro-
duced in insect cells (11). These workers found that highly
purified Dna2 cleaves single-stranded DNA endonucleolyti-
cally, that it prefers 59 single-stranded tails to 39 single-
stranded tails, and that it has very low endonuclease activity
on limited stretches of single-stranded DNA flanked by two
regions of duplex (11). Thus, it has the specificity to tailor the
59 ends of Okazaki fragments during their maturation into
continuous DNA strands, providing a biochemical basis for a
role in Okazaki fragment maturation. Although several heli-
case/nucleases are required for DNA repair, Dna2 is the first
replication protein that contains both functions.
Herein, we further characterize the Dna2 nuclease/helicase
biochemically and genetically. Our results highlight the fact
that Dna2 is a vigorous endonuclease, as opposed to a strictly
structure-specific nuclease, and that it is regulated by ATP.
More important, we show by mutations that eliminate nuclease
activity but that leave helicase intact, that the nuclease is
integral to Dna2 and that the nuclease domain is essential both
for viability of yeast and for repair of x-ray induced damage.
EXPERIMENTAL PROCEDURES
Strains Used—Yeast strains used were: BJ5459 (MATa ura3–52 trp1
lys2–801 leu2D200 his3D200 pep4D:1–1153 prb1D1.6r) and 4X154–2D
(MATa ura3–52 trp1 his3 leu2). Strain dna2–1 for complementation
analysis was as described (10). The strain used for the x-ray sensitivity
study (Fig. 6E) was MB-2–2-5G-6A (MATa trp1 leu2 ura3 his3
dna2–2::LEU2 sgs1–3::TRP1).
Oligonucleotides—Oligonucleotides used for construction of mutants
and helicase and nuclease assays were: MB55, GGAATGCCAGGGAC-
TGGGGAAACTACTGTTATCGCAGA; MB87, GTTCTTCTGTGGCGT-
TCCAGGACCACCCAAGCTAGCGTAGTCTGGGACGTCGTATGGGT-
ACATATGGACGATCTCTTCAATTG; MB95, AAATAATACATCGGAA-
TTTAGCACCAACAGGTT; MB94, GAAGCTCTTCTTATTCCCCGGAT-
CCTCAATGGTGATGGTGATGGTGACTTTCATACTCTTGTAGAAT;
MB140, TATTGGAGACCAAATGTTCGCTGCCGCTGCAATCACATT-
GGATATAGA; hpr3, AGCTCTTGATCGTAGACGTTGTAAAACGACG-
GCCAGTG; hpr7, AGCTAGCTCTTGATCGTAGACGTTGTAAAACGA-
CGGCCAGTG; hpr8, AGCTCTTGATCGTAGACGTTGTAAAACGACG-
GCCAGTGCCAAGC (44-mer, 30 nt complementary to M13mp18).
Plasmids—The plasmid pB/S:DNA2 has the 6110-bp EcoRI fragment
containing the DNA2 gene cloned into the EcoRI site of pB/S SK2. The
next B/S plasmids were created by site-directed mutagenesis with the
above oligonucleotides. The plasmid B/S:87 has the hemagglutinin (HA)
epitope YPYDVPDYASLGGP fused to oligonucleotide AA1 and was
created by hybridizing pB/S:DNA2 with MB87. In addition an EcoRI
site was inserted 3 nucleotides upstream of the ATG. The plasmid
B/S:87.94 was constructed by hybridizing B/S:87 with MB94, creating a
DNA2 gene with a HA epitope tag at the N terminus and 6-histidine tag
at the C terminus. The plasmid B/S:87.94.55 was created by hybridizing
MB55 to B/S:87.94, resulting in a K1080E mutation in the ATP binding
motif. B/S:87.94.95 was created by hybridizing MB95 to B/S:87.94,
resulting in a P504S dna2–1 mutation. The plasmid B/S:87.94.140 was
made by hybridizing MB140 to B/S:87.94, resulting in a DIEE640AAA
mutation. The plasmid pGAL:DNA2 was created by cloning the 5.4-kb
EcoRI fragment from B/S:87.94 into the EcoRI site of pGAL18. The
plasmid pGAL:Dna2:K1080E was created by cloning the 5.4-kb frag-
ment from B/S:87.94.55 into the EcoRI site of pGAL18. The plasmid
pGAL:Dna2:E640A was created by cloning the 5.4-kb EcoRI site from
B/S:87.94.140 into the EcoRI site of pGAL18. The pGAL plasmids
containing the tagged D657A, E675A, and Y293A mutant Dna2 pro-
teins were created exactly as pGAL:Dna2:E640A. Oligonucleotides used
for mutagenesis are available on request. The plasmid pGAL:Dna2:
P504S was created by cloning the 5.4-kb EcoRI fragment from B/S:
87.94.95 into the EcoRI site of pGAL18.
The baculovirus expression vector was prepared by inserting the
full-length DNA2 gene in pB/S SK2 using the 6-kb EcoRI insert from
Ycp154–2 containing the DNA2 gene (2). A BamHI site was engineered
at the ATG translation start site of the DNA2 gene by site-directed
mutagenesis with oligonucleotides GATCGTCAGGGGATCCATGCC-
CGG after purification of U-rich single-stranded phagemid as described
in the Muta-Gene in vitro mutagenesis kit (Bio-Rad). Full-length DNA2
was transferred to the baculovirus expression vector pFASTbac HTb
(Life Technologies, Inc.), containing a 6xHis tag, using BamHI and XhoI
to give pbacDNA2. This yields a 6xHis tag at the N terminus of DNA2.
The plasmid pbacDNA2N, containing the N-terminal 2980 bp of DNA2
was prepared by deletion of the PvuII-ShoI fragment within the DNA2
gene. pbacDNA2C was prepared by cloning of the C-terminal 1719 bp of
DNA2, prepared by polymerase chain reaction, into pFASTbacHTb.
Purification of Dna2 from Baculovirus-injected SF9 Cells—Yeast
Dna2 was expressed in insect SF9 cells using the Bac to Bac baculovirus
expression system (Life Technologies, Inc.). pFast Dna2 was introduced
into Escherichia coli DH10BAC and placed on LB agar containing 50
mg/ml kanamycin, 7 mg/ml gentamycin, 10 mg/ml tetracyclin, 100 mg/ml
Bluo-gal, and 40 mg/ml isopropyl-1-thio-b-D-galactopyranoside as de-
scribed in the supplier’s manual. White colonies were picked and grown
in LB medium containing 50 mg/ml kanamycin, 7 mg/ml gentamycin, 10
mg/ml tetracyclin, and recombinant bacmid DNA was prepared. Bac-
mids were prepared and introduced into SF9 (or HI5) insect cells using
Cell-fectin reagent; recombinant virus were collected and amplified.
Cells were washed with cold Tris-buffered saline buffer and resus-
pended in lysis buffer (25 mM Tris-HCl, pH 7.5, 1 mM EDTA, 100 mM
NaCl, 10% glycerol, and protease inhibitor mix). Cells were lysed by
sonication. After cell extracts were cleared by centrifugation at 10,000
rpm at 4 °C, the supernatant was loaded onto a 5-ml heparin-Sepharose
column. Dna2-containing fractions were collected with lysis buffer con-
taining 600 mM NaCl after several washes with lysis buffer. The frac-
tion was incubated with Ni21/NTA-agarose) equilibrated with binding
buffer for 2 h at 4 °C. After thorough washing with lysis buffer (100
column volumes), Dna2 was eluted with a gradient from 0 mM to 150
mM imidazole in lysis buffer. The Dna2-containing fraction was dia-
lyzed in 10 volumes of lysis buffer.
The Dna2-containing fraction was loaded onto a 1-ml FPLC Mono Q
column. After washing, Dna2 was eluted with a gradient of 100–600
mM NaCl in lysis buffer. Dna2-containing fractions (eluting at 270 mM
2 The abbreviations used are: DSB, double-strand break; HA, hemag-
glutinin; 12CA5, anti-HA monoclonal antibody; nt, nucleotide(s); kb,
kilobase pair(s); bp, base pair(s); BSA, bovine serum albumin; DTT,
dithiothreitol; NTA, nitrilotriacetic acid; TBSG, Tris-buffered saline
plus glycerol.
FIG. 1. Schematic diagram of the
yeast DNA2 gene.
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NaCl) were pooled and loaded onto a 5-ml 15–40% glycerol gradient and
centrifuged at 45,000 rpm in a SW 50.1 rotor for 24 h. Dna2 was
identified at all purification steps by DNA-dependent ATPase assay and
Western blotting with anti-Dna2 polyclonal antibody. A summary of the
purification is shown in Table I.
Purification of Dna2 from Yeast—The pGAL18 plasmids described
above were transformed into BJ5459, and cells were grown and extracts
were prepared as described previously (2). To purify Dna2 on the
Ni21/NTA-agarose column, the ammonium sulfate precipitated extract
was dialyzed in TBSG, pH 8.0, 0.1% Triton X-100 (0.025 M Tris, pH 8.0,
0.15 M NaCl, 10% glycerol, 0.1% Triton X-100). Protein (100 mg) was
loaded onto a 1-ml Ni21/NTA-agarose column. The column was washed
with 50 volumes of TBSG, pH 8.0, 0.1% Triton X-100. The column was
further washed with 20 mM imidazole in TBSG, pH 8.0, 0.1% Triton
X-100. His-tagged Dna2 was eluted with 200 mM imidazole in TBSG,
pH 7.6, 0.1% Triton X-100. The protein was concentrated to 1 mg/ml and
frozen. Approximately 100-fold purification was obtained.
Dna2 was immunoprecipitated by incubating 5 mg of Ni21/NTA-
agarose-purified Dna2 with 5 mg of 12CA5 antibody for 1.5 h at 4 °C. 10
ml of 10% protein A beads was added followed by a 1-h incubation.
Beads were washed five times with TBSG, pH 7.6, 0.1% Triton X-100, 1
mg/ml BSA, then two times with 23 assay buffer. 23 ATPase assay
buffer is 20% glycerol, 0.08 M Tris, pH 7.6, 0.01 MgCl2, 0.05 M NaCl,
0.002 M DTT, 1 mg/ml BSA. 23 helicase assay buffer is 20% glycerol,
0.08 M Tris-HCl, pH 7.3, 0.01 M MgCl2, 0.05 M NaCl, 0.002 M DTT, 1
mg/ml BSA. 12CA5 was coupled to CL-4B-agarose beads at a concen-
tration of 10 mg/ml. When 12CA5-coupled beads were used, 5 mg of
Ni21/NTA-purified protein was incubated with 5 ml of 12CA5-coupled
beads for 2 h. The protein was then washed as above. When Dna2 was
purified from ammonium sulfate precipitates of crude extracts, 0.5 mg
of protein was incubated with 10 mg of 12CA5 for 1.5 h, followed by the
addition of 10 ml of 10% protein A beads. The substrate was added in a
volume of 10 ml and incubated at 37 °C.
Helicase and ATPase Assays—The helicase assay contained 4 mM
ATP, 0.01 pM oligonucleotide hpr3 hybridized to M13. 23 helicase assay
buffer is 20% glycerol, 0.08 M Tris-HCl, pH 7.3, 0.015 M MgCl2, 0.05 M
NaCl, 0.002 M DTT, 8 mM ATP. The standard ATPase assay contained
0.1 mg/ml poly(dA) and 0.2 mM ATP at 25 mM/1 mCi.
Preparation of Nuclease Substrates and Nuclease Assays—For 59-
labeled substrate, oligonucleotides were labeled at the 59 end with 32P
using polynucleotide kinase. Labeled oligonucleotides were hybridized
to M13mp18 by heating to 65 °C for 5 min and annealing by cooling to
room temperature. Free oligonucleotides were removed by gel filtration
using Sepharose CL-4B. For 39-labeled substrate, the oligonucleotide
was annealed to M13mp18 DNA and labeled using Klenow enzyme and
[a-32P]dTTP. Unincorporated dTTP was removed by gel filtration.
Purified Dna2 was incubated in a 20-ml reaction (same as ATPase
reaction) containing 15 fmol of substrate at 37 °C for 15 min. For
denaturing gel analysis, after mixing with sequencing gel loading
buffer, samples were boiled and loaded onto a 20% sequencing gel. The
gel was run for 90 min at 20 W. Gels were dried and the nuclease
products were analyzed with the PhosphorImager (Molecular
Dynamics).
RESULTS
Expression of DNA2 in Baculovirus-infected Insect Cells—
The DNA2 gene used in this study contains the full-length
DNA2, including the 105-amino acid, N-terminal segment ab-
sent from the gene used in our previous studies (2). This region
does not appear to perform an essential function and shares no
homology with DNA2 genes from other organisms. However,
the 105-amino acid region may have a role in transcriptional
silencing, since overexpressing this portion of the protein leads
to derepression of genes normally silenced at telomeres (22). In
evaluating the essential functions of DNA2, it seems more
prudent to use the full-length protein.
The DNA2 gene was tagged at the N terminus with 6 histi-
dines, cloned, expressed in SF9 insect cells, and extensively
purified as described under “Experimental Procedures” and
Table I. In addition to the wild type protein, a K1080E mutant
protein, a protein consisting of the 963 N-terminal amino acids
(120 kDa), and a protein consisting of the 573 C-terminal
amino acids (65 kDa) were expressed and purified. Similar
levels of expression and purity were obtained with each of the
mutant proteins (Fig. 2). To determine if Dna2, like other
helicases, is multimeric, gel filtration analysis was carried out.
The Dna2 protein is found primarily as a dimer (Fig. 3). In
addition, there is a significant peak of tetramers (Fig. 3) and
even some hexamers (not visible in the tracing in Fig. 3). Only
the dimeric form of the Dna2 protein shows DNA-dependent
ATPase activity, suggesting that the form of the protein active
as an ATPase is a dimer (Fig. 3).
DNA-dependent ATPase and Helicase Activity—As shown in
Fig. 4A, the ATPase activity of the wild type protein requires
single-stranded DNA. Either poly(dA) or single-stranded circu-
lar M13 DNA is an effective cofactor. Double-stranded DNA
fails to stimulate the ATPase. The K1080E mutation abolishes
the ATPase activity (Fig. 4A), identifying the Walker A box as
part of the active site of the DNA-dependent ATPase. The
N-terminal 120-kDa protein and the C-terminal 65-kDa pro-
tein both lack ATPase (Fig. 4A), suggesting that the two do-
mains may interact to activate the ATPase or that the C-
terminal fragment does not fold properly, even though it is
expressed at levels similar to the wild type (data not shown).
The Km for the ATPase activity was determined from the data
in Fig. 4B and is 165 mM. Since we have previously shown that
4 mM ATP is required for the DNA helicase activity (2), the low
Km was surprising. Below, we reconcile this discrepancy by
showing that much lower concentrations of ATP (100 mM) are
required for helicase activity when the nuclease is inactivated
by mutation. It is noteworthy that the specific activity of the
ATPase associated with yeast Dna2 is almost 100 fold higher
than that found in X. laevis Dna2 (8), suggesting that there
may be some differences between the enzymes from different
species.
As reported previously for yeast Dna2 expressed in insect
cells and for Xenopus Dna2 expressed in insect cells (8, 11), at
the levels of protein used here, there was no detectable helicase
activity in our preparations on any of the substrates used to
assay the activity of the Dna2 protein purified from yeast (for
example Fig. 5A). The difficulty of detecting helicase in recom-
binant Dna2 is further addressed under “Discussion” but is not
the subject of this paper, which focuses on the nuclease activity.
Nuclease Activity of Dna2—The Dna2 preparations are ac-
tive as nucleases. To further characterize the substrates and
products of the Dna2 nuclease activity, we chose substrates,
labeling configurations, and reaction conditions not investi-
gated previously with the recombinant yeast Dna2 protein
from insect cells (11). In addition, we compared the wild type
Dna2 protein with the K1080E mutant protein. First, we used
the helicase substrate, an M13 single-stranded DNA circle
hybridized to a 38-nt oligonucleotide with a 14-base noncomple-
mentary 59 tail (2). The 38-mer was labeled at the 59 terminus
with 32P. The digestion products were analyzed on a native gel.
As shown in Fig. 5A (lanes 2, 4, 7, 9, 11, and 12), the major
labeled product of the nuclease was 10 nt, with some smaller
products, suggesting a preference for cutting this substrate 4 nt
away from the junction of duplex and single-stranded DNA (but
see below). Lanes 1 and 6 are controls with protein from mock-
infected insect cells carried through the same purification pro-
cedure. The K1080E mutant was as active as the wild type
TABLE I
Purification of 6xHis-Dna2 from insect cells
Amount Volume Specific activity
mg ml mmol/30 min/mg
Extract 80 8
Heparin-agarose 18 10 0.35
Ni21/NTA 2.8 4 2
Mono Q 0.03 1.5 129
Glycerol gradient 0.01 0.5 160
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protein (compare lanes 2 and 4, 3 and 5, 7 and 9, 11 and 12).
When a substrate with an 18-nt 59 tail was used, the major
product was 14 nt (data not shown). These results could sug-
gest that the enzyme monitors distance from the fork. A similar
spectrum of products is seen with the enzyme purified from
yeast (see Fig. 10).
Since we were concerned that the nuclease might mask the
helicase activity by destroying the substrate, we searched for
conditions that might inhibit the nuclease preferentially. As
shown in Fig. 5A, a combination of 2 mM ATP and 2 mM Ca21
completely inhibited the nuclease (lanes 3 and 5), yet helicase
activity still was not seen. The boiled substrate is shown in lane
13 to indicate where the product of the helicase would appear.
Comparison of lanes 3 and 5 in Fig. 5A, which contain both ATP
and Ca21, to lanes 8 and 10, which contain only Ca21, shows
that Ca21 alone was less inhibitory than Ca21 plus ATP.
(Lanes 11 and 12 of Fig. 5A are similar to lanes 3 and 5, but
contain only 1 mM Ca21.) Comparison of lane 2 (with ATP) with
lane 7 (no ATP) shows that ATP is inhibitory by itself. Note the
increase in smaller products in lane 7. We have consistently
observed that ATP is inhibitory to the nuclease activity of wild
type Dna2 (2, 9), and see below. ATP inhibition is not a result
of titration of Mg21, since 1 mM excess Mg21 was added in the
reactions containing ATP and no Ca21.
In Fig. 5B, we show the labeled products of the reaction when
Dna2 is incubated with the same configuration of substrate but
with the radioactive label at the 39 terminus of the oligonucleo-
tide, which is in a duplex structure. In this experiment, the
duplex region is 30 bp long and the tail is 14 nt. As opposed to
the native gel shown in Fig. 5A, a denaturing polyacrylamide
gel was used in order to detect potential cutting in the duplex
portion of the substrate. The major product, as revealed after
denaturation, is clearly 30 nt in length, with minor products of
29 and 31 nt. The size of the products labeled at the 39 end
suggests that there is significant cutting at the junction of the
single-stranded 59tail and duplex DNA, that is at the fork. This
activity is due to Dna2 protein since it is inhibited by Dna2
antibody, shown in Fig. 5C. Taking the results of Fig. 5, panels
A and B, together, we infer that the endonuclease cleaves at the
junction, releasing the single-stranded 59 product, which may
then be further degraded. The smaller products are not detect-
able when label is only at the 39 end. The 30-nt duplex, by
contrast, is stable to further digestion by Dna2, but detectable
only when label is at the 39 end. Comparison of the amount of
degradation in Fig. 5 (A and B) suggests that the enzyme
prefers the single-stranded tail to the junction, although it is
difficult to quantify the difference in preference. It is clear that
Dna2, like FEN-1, can cleave a flap structure. However, Dna2,
unlike FEN-1 (13), has a potent activity as a single-stranded
endonuclease, yielding products of 10 nt in length and smaller.
Thus, the specificities of Dna2 and FEN-1 are overlapping but
not identical.
To verify that Dna2 cleaves single-stranded DNA, the 42-nt
oligonucleotide, in the absence of M13, was labeled at the 59
end. After incubation with enzyme, the major products were 10
nucleotides or less (data not shown). Completely single-
stranded circular DNA was then used to determine whether
the enzyme had any preference for ends, as might be found on
immature Okazaki fragments. When M13 circular DNA was
used as substrate, it was cleaved to linear, full-length DNA
(Fig. 5D). Over 60% of the substrate was converted to linear
DNA before any fragments smaller than unit length were ob-
served. This is the same pattern of cleavage observed with the
RecB nuclease, and suggests that on long DNA molecules Dna2
has no preference for DNA ends over internal sites and that the
enzyme is distributive under these assay conditions. This does
not rule out that the endonuclease may prefer short tails adja-
FIG. 2. Purification of Dna2 from baculovirus-infected insect
cells. 6xHis-Dna2 was purified from insect cells infected by recombi-
nant 6xHis-Dna2 baculovirus as described under “Experimental Proce-
dures” and in Table I. Lanes 1–4, silver-stained gel. Lane 1, cell ex-
tracts; lane 2, Ni21/NTA column eluted fractions; lane 3, Mono Q
fraction; lane 4, glycerol gradient fraction. A mock purification was
carried out in parallel with cells infected with virus lacking insert.
Lanes 5–10, Western blot using Dna2 polyclonal antibody. Lane 5, mock
cell extracts; lane 6, mock Ni21/NTA column flow-through; Lane 7, mock
Ni21/NTA column eluted fraction; lane 8, 6xHis-Dna2 cell extracts; lane
9, 6xHis-Dna2 Ni21/NTA column flow-through; lane 10, 6xHis-Dna2
Ni21/NTA column eluted fraction.
FIG. 3. Size exclusion analysis of
Dna2. Partially purified Dna2 (0.5 mg,
Ni21/NTA-agarose fraction) was loaded
onto an FPLC Superose 6 HR 10/30 col-
umn. Fractions (0.5 ml) were collected
and analyzed by Western blotting using
anti-Dna2 polyclonal antibody. The rela-
tive amount of Dna2 in each fraction was
measured by densitometer tracing of the
Dna2 Western blot. ATPase activity was
assayed with 2 ml of each fraction in 20-ml
reactions in the presence of 0.2 mM ATP
for 30 min. The column was calibrated
with thyroglubulin (669 kDa), ferritin
(440 kDa), and aldolase (158 kDa). The
peaks of these markers were in fractions
25, 29, and 32, respectively. f, Dna2; l,
ATPase activity.
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cent to short single-stranded regions within duplex DNA,
where the single-stranded DNA may be too short for efficient
binding of Dna2 protein. Other studies suggest that single-
stranded tails are preferred to single-stranded regions flanked
by duplex DNA when oligonucleotides are used as substrates
(11).
Mutations Affecting the Nuclease Activity of Dna2 and Their
Effects on Growth of Yeast and Repair of Double-strand
Breaks—Two lines of evidence suggest but do not prove that
Dna2 encodes the nuclease activity. First, the nuclease activity
copurifies with Dna2 from a rad27D mutant and with Dna2
from insect cells expressing only yeast Dna2 and not yeast
FEN-1. Second, the substrate specificity of FEN-1 differs from
that of Dna2. To obtain further evidence that the nuclease is
intrinsic to Dna2, to examine the location of the nuclease do-
main in the protein, and to determine if the activity is part of
the essential function of Dna2, we have made mutations that
target the nuclease. Since at the time this work was begun, we
could detect no homology within Dna2 with any known nucle-
ase motifs, our rationale was as follows. The nuclease is prob-
ably associated with the N terminus, since helicase occupies
the C terminus. Therefore, the first mutation we introduced
into the full-length Dna2 protein is the N-terminal dna2–1
mutation, P504S, originally identified by us (9). This amino
acid falls in a region strictly conserved among all Dna2 or-
thologs. The second mutation was designed to target putative
nuclease catalytic residues. Dna2 is a Mg21-dependent nucle-
ase. Metal catalyzed nuclease reactions often require aspartic
and glutamic acids as ligands for Mg21. In the Exo1 domain of
E. coli DNA polymerase I, there are two aspartic acid residues
in a row and these are conserved in Exo domains from other
bacterial and eukaryotic DNA polymerases with 39 to 59 exo-
nuclease activity (23). Altering the nuclease activity of Dna2
might involve mutating two or more conserved aspartic or
glutamic amino acid residues. The residues DIEE beginning at
amino acid 640 are conserved among human, C. elegans, and X.
laevis Dna2 and were therefore deemed candidates for essen-
tial catalytic residues. These amino acids were changed to
AAAA by site-directed mutagenesis as described under “Exper-
imental Procedures.”
Since the time that we constructed the latter mutant, a study
has appeared proposing that a region 11 amino acids down-
stream of amino acid 640 is homologous to the putative nucle-
ase active site of the RecB nuclease family (24). Three addi-
tional mutations were then introduced on the basis of the
conservation with RecB nuclease. Asp657, Glu675, and Tyr693
were changed to alanine. Mutation of the amino acid in RecB
equivalent to Dna2 Glu675 eliminates the nuclease activity of
RecB protein, D1080A (24, 25).
A sixth mutation, K1080E, was introduced into the Walker
ATP binding loop. We have already described both the catalytic
and functional properties affected by this mutation in the N-
terminally 105 amino acid truncated form of Dna2. However,
since we had not characterized the full-length Dna2 protein
containing this change, the new K1080E mutant serves as an
important control (2).
The wild type and six mutant genes, P504S, E640A, D657A,
E675A, Y690A, and K1080E, tagged with 6xHis at the C ter-
minus and with the HA epitope at the N terminus, were cloned
into the multicopy vector pGAL18 downstream of the galactose-
inducible, glucose-repressible yeast GAL10 promoter. As illus-
trated in Fig. 6A, the DNA2 gene complemented the dna2–1
FIG. 4. ATPase activity of purified
Dna2 and mutant proteins expressed
in baculovirus-infected insect cells.
A, DNA requirement. 6xHis-Dna2 (2 ng)
was incubated with various DNA cofac-
tors. M13, double-stranded DNA (linear-
ized pRS304) and poly(dA) were each
present at 2 mg. ATPase was assayed as
described under “Experimental Proce-
dures.” B, level of ATPase. The assay was
carried out as described under “Experi-
mental Procedures” with 2 ng of 6xHis-
Dna2.
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strain even without induction (glucose plate). We conclude that
when Dna2 is cloned on a multicopy plasmid there is sufficient
expression for complementation of dna2–1 even under glucose
repression. None of the remaining genes, E640A, P504S,
D657A, E675A, Y640A, or K1080E, complemented the dna2–1
mutant at 37 °C on glucose plates (Fig. 6, A and E).
When the various DNA2 genes were induced with galactose
(Fig. 6B), both the wild type and the P504S protein were able to
restore growth to the dna2–1 mutant strain at 37 °C, whereas
the K1080E, E640A, D657A, E675A, and Y693A mutants were
unable to complement. (Only K1080E and E640A are shown
here, but see Fig. 6F.) Complementation by high levels of
mutant dna2–1 protein indicates that there is some residual
active dna2–1 protein at 37 °C, and simply increasing the
amount allows cell growth. Since none of the other proteins
complemented under any conditions, these are likely loss of
function mutations.
In addition to being loss of function mutations, the E640A,
D657A, E675A, and Y693A mutations are dominant negative
when the proteins are overproduced (Fig. 6, C, D, and F).
Overexpression of the E640A protein at 37 °C in a wild type
strain (Fig. 6C) and at the permissive temperature in dna2–1
strains (Fig. 6D) is lethal. The relative plating efficiency on
galactose versus glucose for the dna2–1 strain expressing the
FIG. 5. Products of endonuclease
activity of wild type and mutant
Dna2 proteins expressed in baculovi-
rus-infected cells. Oligonucleotide was
annealed to M13mp18 and reactions car-
ried out as described under “Experimen-
tal Procedures.” Products were analyzed
on a neutral gel. A, substrate labeled at
the 59 end, 38-nt hpr 3 oligonucleotide.
Lanes 1 and 6, protein from extract of
cells infected with virus lacking the Dna2
gene carried through the affinity purifica-
tion procedure. Lanes 2, 3, 7, 8, and 11 are
6xHis-Dna2 protein. Lanes 4, 5, 9, 10, and
12 are 6xHis-Dna2K1080E protein. Lanes
1–5 test the effect of ATP on the activities
of Dna2. They contain 4 mM ATP in addi-
tion to the normal reaction mixture.
Lanes 2 and 4 contain ATP only. Lanes 3
and 5 also contain 2 mM CaCl2in addition
to ATP. Lanes 6–10 test the nuclease in
the absence of ATP but in the presence of
CaCl2. These reactions contain no ATP,
but lanes 8 and 10 contain 2 mM CaCl2.
Lanes 11 and 12 are similar to lanes 3
(6xHis-Dna2) and 5 (6xHis-Dna2K1080E)
except they contain only 1 mM CaCl2.
Lane 13 is boiled substrate, no protein. B,
substrate labeled at the 39 end, hpr 8 oli-
gonucleotide. Products of reactions were
boiled and analyzed on a denaturing ac-
rylamide gel. Lanes 1 and 2 are boiled
substrate and substrate incubated with
protein purified from extracts lacking re-
combinant 6xHis-Dna2 virus, respec-
tively. Lanes 3–6, increasing amounts of
Dna2. C, inhibition of Dna2 nuclease by
Dna2 antibody. Lane 1, boiled substrate;
lane 2, preserum but no Dna2 protein,
with substrate labeled at the 39 end.
Lanes 3–7 contain Dna2 plus increasing
amounts of preserum, and lanes 9 and 10
contain Dna2 plus increasing amounts of
antibody. Lane 8, Dna2 antibody, no Dna2
protein. D, circular M13mp18 DNA as nu-
clease substrate. Lane 1, no Dna2; lane 2,
mock-infected control; lanes 3–7, increas-
ing amounts of Dna2.
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FIG. 6. Effect of dna2 mutations in vivo. Growth and x-ray sensitivity of yeast dna2–1 and DNA2 strains transformed with plasmids pGAL18,
pGAL:Dna2, pGAL:Dna2:E640AA, pGAL:Dna2:P504S, and pGAL:Dna2:K1080E was measured on either glucose- or galactose-containing plates.
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E640A mutant from the GAL promoter was quantitated (Table
II) and found to be 3 3 1024, whereas the relative plating
efficiency of plasmid free dna2–1 cells or dna2–1 cells carrying
plasmids expressing the P504S and K1080E mutants was unity
(Table II). The D657A, E675A, and Y693A mutations are also
lethal in dna2–1 plated on galactose at the permissive temper-
ature (Fig. 6F). The ability to function as dominant negatives
can be explained if the mutant proteins can assemble in repli-
cation complexes but are inactive.
Sensitivity of Mutants to X-rays—dna2–1 and dna2–2 mu-
tants are sensitive to x-rays and to methylmethane sulfonate
(4, 5). Since this x-ray sensitivity is suppressed by overproduc-
tion of FEN-1 (5), and since the nuclease activity of Dna2 is
similar to that of FEN-1, we tested the ability of the new
mutants to restore x-ray resistance to dna2–2 mutants. The
wild type but not K1080E or E640A rescued the x-ray sensitiv-
ity of dna2–2. Thus, as shown in Fig. 7, the activities affected
by mutations in both the C-terminal ATP domain and the
N-terminal domain are required for efficient repair of x-ray
damage. As shown under “Experimental Procedures,” the
dna2–2 strain used here also contained a mutation in an addi-
tional helicase, sgs1D. However, sgs1D mutants are not sensi-
tive to x-rays (26).
Expression of Mutant Proteins in Yeast and Definition of the
Enzymatic Activities of the Mutant Proteins—The DNA2 genes
were expressed in yeast, rather than in insect cells, so that the
helicase activity could also be monitored. To allow for two
affinity purification steps, the Dna2 proteins were fused to a
6xHis tag at the C terminus and an HA tag at the N terminus
as described under “Experimental Procedures.” As illustrated
in Western blots shown in Fig. 8D, the wild type, E640A,
P504S, and K1080E proteins were expressed and recovered
after purification at approximately equal levels. The other pro-
teins were expressed at similar levels (data not shown).
DNA-dependent ATPase—Ni21/NTA affinity-purified pro-
teins (see Experimental Procedures) were assayed for DNA-
stimulated ATPase at 23 °Cand 37 °C. As shown in Fig. 8A, the
Dna2 and E640A proteins have nearly equivalent levels of
ATPase. The K1080E protein, as expected, is defective (9). The
K1080E curve serves as control to demonstrate that Dna2 is
the only ATPase in the purified fractions. What was surprising
is that the activity of the P504S (the dna2–1 mutation) protein
is only slightly greater than the K1080E protein, since the
P504S mutation does not map to the predicted ATPase domain.
The P504S protein does not appear to be temperature-sensi-
tive, but rather is defective at all temperatures. The reduced
ATPase activity of the N-terminally located mutation suggests
that the N terminus may be a positive effector of the ATPase
activity of Dna2p, perhaps a DNA binding domain. Although
global unfolding cannot be ruled out, it is worth noting that the
P504S protein is active in vivo when overproduced, suggesting
that at least in vivo the residual activity is sufficient for
function.
To demonstrate that the ATPase of the P504S mutant was
partially active, Ni21/NTA-purified Dna2 and the P504S pro-
tein were immunoprecipitated with CL-4B beads coupled with
12CA5 in order to further purify and concentrate the protein.
The additional purification step removed the small fraction of
non-DNA-dependent ATPases from the Dna2 so that longer
incubation times and higher specific activity ATP could be used
in the assay. When this preparation was assayed, and the ATP
concentration was reduced to 50 mM, the P504S protein now
showed approximately 50% the extent and rate of ATPase
activity as wild type, whereas the K1080E mutant remained
inactive (Fig. 8C).
As shown in Fig. 8B, the Glu675 and Tyr693 mutants show
similar, though slightly reduced ATPase activity compared
with this preparation of wild type. The Asp657 mutant shows a
lower rate and extent, about 40% of wild type. The significance
of these small differences is not clear since the helicase of these
mutants does not appear different from wild type (see Figs. 9
and 10). There could be variations in recovery of the proteins
that prevent accurate quantitation within a 2-fold range.
DNA Helicase and Nuclease—In order to test the mutant
proteins for the helicase and nuclease activities, Dna2 proteins
were purified from the Ni21/NTA column and immunoprecipi-
tated with 12CA5 antibody. Note that these purification steps
are different from those used previously and that two affinity
purification steps are employed rather than one (2, 9). As
shown in Fig. 9 (lane 5), the reaction containing Dna2 and ATP
yields three bands: a major one of 38 nt, a minor product of
approximately 34 nt, and a major product consisting of oligo-
nucleotides of products of approximately 10 nt. We propose that
the 38-mer is due to helicase activity acting at the fork between
the 59 tail and the duplex region. Controls show that in the
absence of Dna2 protein, no helicase is observed (Fig. 9, lane
12). In the presence of Dna2 and absence of ATP, there is also
no helicase activity (Fig. 9, lane 4, no 38-nt band).
A, top. Strain 4X154–2D, dna2–1, transformed with the plasmids carrying the dna2 alleles indicated, and grown on glucose containing plates at
37 °C. B, bottom. Strain 4X154–2D, dna2–1, transformed with the indicated plasmids, and grown on raffinose/galactose-containing plates at 37 °C.
C, dominant negative effect of E640A. Strain BJ5459,DNA2, transformed with indicated plasmids and grown at 37 °Con raffinose/galactose-
containing plates. D, strain 4X154–2D, dna2–1, transformed with the indicated plasmids and grown at 23 °C. E, strain 4X154–2D, dna2–1,
transformed with the indicated plasmids and grown at 35 °C. F, dna2–1 transformed with the indicated plasmids and grown at 23 °C.
TABLE II
Dominant lethality of overexpression of dna2, E640A,
in the dna2–1 mutant
Strain 4X154-2D was transformed with the above plasmids, grown in
uracil-deficient glucose media to log phase, serially diluted and plated
on uracil-deficient, glucose or raffinose/galactose-containing media.
Plasmid Ratio survival on galactose/glucoseat 23 °C
pGAL18 1.02
pGAL18:DNA2 0.97
pGAL18:DNA2:P504S 0.95
pGAL18:DNA2:K1080E 0.94
pGAL18:DNA2:E640A 0.0003
FIG. 7. Ability of various dna2 mutant genes to rescue x-ray
sensitivity of yeast dna2–2 strains. dna2–2 cells transformed with
the plasmids indicated on the right were harvested in log phase, irra-
diated, serially diluted, and plated on uracil-deficient glucose-contain-
ing plates, as described (5, 50). The plasmids are high copy number
plasmids, which allow expression of the various Dna2 proteins with
glucose.
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We propose that the 34-mer is due to helicase at the 39 end of
the duplex followed by nucleolytic degradation of the exposed 39
single-stranded region, since it is not seen in the minus ATP
reaction (Fig. 9, lane 4). This activity was suppressed in our
former work by the introduction of a thiophosphate ester in the
39 terminal phosphodiester bond of the oligonucleotide (2), but
was reported by Bae et al. (11).
The much more abundant labeled product migrating with
oligonucleotides of 14 nt or less in length indicates that Dna2
nuclease activity cuts the 59 flap region in the presence of ATP.
This nuclease activity is not only ATP-independent (lane 4), it
is actually inhibited by ATP (compare lanes 4 and 5). In the
mock immunoprecipitate, that is, in the absence of 12CA5, a
small amount of helicase and nuclease activity is observed, but
much less than in the presence of antibody. It is likely a small
amount of protein precipitates in the presence of high concen-
trations of BSA that are needed to stabilize the ATPase activity
and helicase activity in the purified fraction. BSA is not needed
when crude Dna2 is immunoprecipitated, probably because
other proteins in the extract serve to stabilize Dna2 (data not
shown).
The E640A mutant retains significant helicase activity in the
presence of ATP (Fig. 9, lane 7, 38-nt band). The helicase is
approximately 60% as active as wild type, estimated from three
experiments, consistent with the estimated reduction in
ATPase of the E640A protein compared with wild type (see Fig.
8). The E640A change has a much greater effect on the nucle-
ase activity than on the helicase and ATPase. The E640A
mutant shows less than 15% of the amount of endonuclease as
wild type in the absence of ATP (lane 6) and has no detectable
nuclease activity in the presence of ATP (lane 7). This is even
more clear evidence than that presented in Fig. 5 with the
insect cell preparation of Dna2, that the nuclease is regulated
by ATP.
Nuclease Activity of Mutations Affecting the RecB Homology
Domain—Mutations in the residues conserved in RecB nucle-
ase have a greater effect on the nuclease than the E640A
change. D657A and E675A show no detectable nuclease activ-
ity either in the absence or in the presence of ATP (Fig. 10A). In
these assays we have used a more sensitive denaturing gel
nuclease assay than was used in the experiment in Fig. 9 to
refine the analysis of the products. Products range from 14 nt
down to a few nt. The Y693A mutant protein shows some,
although reduced, nuclease activity in the absence of ATP, but
no activity in the presence of ATP (Fig. 10A), similar to E640A
(Fig. 9). Overexposure of the Dna2 protein lane (panel on the
right) shows that wild type nuclease is inhibited by ATP but
also shows that there is some ATP-dependent cutting (faint
bands between 32 and 14 nucleotides in length). We propose
that the ATP binding domain can modulate the activity of the
nuclease, since nuclease is always reduced or altered in the
presence of ATP, and is completely abolished by ATP in the
E640A and Y693A mutants.
Helicase Activity Is Intact in All Four Nuclease Mutants—An
important point is that the E640A, D657A, E675A, and Y693A
mutant proteins, although deficient in nuclease, are all active
helicases (Fig. 10B). Thus, the inability of these mutants to
support growth (Fig. 6, A–F, Table II) is clearly due to a nucle-
ase defect. In addition, the inability of the E640A mutant to
complement the x-ray repair defect in a dna2–2 mutant is also
likely due to the nuclease deficiency (Fig. 7). This ability to
selectively inactivate nuclease but not helicase also shows that
FIG. 8. DNA-stimulated ATPase ac-
tivity of wild type and mutant Dna2
proteins purified from yeast. A and B,
ATPase assays of Ni21/NTA-agarose-pu-
rified proteins. Assays contained ATP at
0.2 mM and 1 mg of Ni21/NTA-agarose-
purified protein. The temperature of incu-
bation is indicated. C and D, ATPase as-
says of double immunoaffinity-purified
proteins. 5 mg of Ni21/NTA-agarose-puri-
fied protein was immunoprecipitated
with 5 mg of 12CA5 coupled to CL-4B
beads. Beads were washed and assayed as
described under “Experimental Proce-
dures.” In panel C, the ATP concentration
is 0.05 mM and the protein was purified
further by immunoprecipitation with
12CA5 antibody as described under “Ex-
perimental Procedures.” D, level of ex-
pression of wild type and mutant Dna2
proteins in yeast. His-tagged, HA-tagged
Dna2 and the indicated mutant proteins
were purified from extracts of yeast
through Ni21/NTA-agarose, loaded onto a
7.5% acrylamide gel, and blotted onto ni-
trocellulose. Filters were probed with the
12CA5 anti-hemagglutinin antibody.
FIG. 9. Comparison of DNA helicase activities of wild type and
mutant Dna2 proteins purified from yeast. A, 5 mg of Ni21/NTA-
agarose-purified protein was immunoprecipitated with 5 mg of 12CA5
anti-HA antibody, followed by addition of 10 ml of 10% protein A beads.
Beads were washed and assayed with oligonucleotide hpr3 hybridized
to M13 as described under “Experimental Procedures.” The contents of
each reaction are shown above each lane. The size of the bands is
indicated on the right in nucleotides. Lane 1, boiled hpr3; lane 2, Dna2,
minus antibody; lane 3, Dna2, minus antibody, 4 mM ATP; lane 4, Dna2,
plus 12CA5; lane 5, Dna2, 12CA5, 4 mM ATP; lane 6, Dna2E640A,
12CA5; lane 7, Dna2E640A, 12CA5, 4 mM ATP; lane 8, Dna2P504S,
12CA5; lane 9, Dna2P504S, 12CA5, 4 mM ATP; lane 10, Dna2K1080E,
12CA5; lane 11, Dna2, K1080E, 12CA5, 4 mM ATP; lane 12, no protein,
no antibody; lane 13, boiled.
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the helicase activity of Dna2 on forked molecules is not depend-
ent on the nuclease. We are aware in drawing these conclusions
that there is a small reduction in DNA-dependent ATPase in
some of these mutants (Fig. 8). However, others have provided
convincing evidence that full ATPase activity is not required
for viability (4).
The availability of the E675A mutant allowed us to reinves-
tigate the Km for ATP of the Dna2 helicase activity in the
absence of nuclease. Using the assay conditions described in
Fig. 10B, we determined a Km of between 70 and 100 mM,
similar to that for ATPase. The 4 mM ATP Km described previ-
ously for the wild type enzyme might be required to inhibit the
nuclease so that helicase can be observed (2).
Helicase Is Deficient in the P504S and K1080E Mutants—
The Dna2 P504S protein, which gives a temperature-sensitive
in vivo phenotype, retains helicase activity, although like its
ATPase activity, the helicase activity is significantly reduced
compared with wild type and E640A (Fig. 9). The P504S mu-
tant also retains nuclease activity, although it is reduced by
about 95% compared with wild type (Fig. 9, compare lanes 8
and 4). The effect of this mutation is different from that of the
E640A and Y693 mutations, since the nuclease activity is not
completely abolished in the presence of ATP, although it may
be slightly further reduced (lane 9). Since the P504S mutation
is temperature-sensitive, the mutation may destroy the confor-
mation of the protein, rather than identifying amino acids
important for one or the other of the activities of Dna2 protein.
For the K1080E protein, helicase is not observed but nucle-
ase is retained at high levels in the presence of ATP, consistent
with our previous results (9). The Dna2 K1080E mutant re-
tains full nuclease activity (compared with wild type) in the
absence of ATP, but unlike the other Dna2 proteins, the
K1080E nuclease activity appears to be stimulated by ATP. We
do not know if there is another ATP binding site in this protein,
but this stimulation is reproducible.
DISCUSSION
Since Dna2 is a multifunctional enzyme, it has been impor-
tant to determine which of the enzymatic activities is required
for the functions of the protein in the cell. We have previously
shown that the ATPase, and presumably the helicase, is essen-
tial. We have now shown by generating separation of function
mutations that the associated single-strand specific endonucle-
ase activity is integral to the Dna2 protein and that it is also
essential for the viability of yeast. Mutations in a conserved
region of the N terminus abolished nuclease activity and only
helicase activity remained. Changing either of two amino acids
in the RecB homology region abolished nuclease in both the
presence and absence of ATP, suggesting that the homology
has functional significance. The nuclease mutants failed to
complement the growth defect of a dna2–1 mutant and showed
a dominant negative affect on growth. This suggests that the
four mutant proteins can associate with the essential replica-
tion complexes in vivo. Thus, we propose that it is the impaired
enzymatic activity that is giving rise to repair and replication
phenotypes rather than a defect in protein/protein interactions.
Although it has previously been proposed that only the helicase
analyzed on 18% denaturing polyacrylamide gels. Markers are a labeled
oligonucleotide ladder from 8 to 32 nt in length, with intervals of two
nucleotides between. The panel at the right is a longer exposure of the
Dna2 protein lane, illustrating weak ATP-dependent cutting. The pro-
tein in each reaction is indicated at the top of the figure. Each protein
was assayed in the absence (2) and presence (1) of 4 mM ATP. B,
helicase activity. Immmunoprecipitates as in A were assayed as de-
scribed under “Experimental Procedures” for helicase activity. The sub-
strate was 42-nt oligonucleotide hpr7 hybridized to M13. Samples were
analyzed on an 18% non-denaturing gel.
FIG. 10. Nuclease and helicase assays of N-terminal, RecB-
homologous mutants. A, nuclease assays. Nuclease assays were car-
ried out in reaction mixtures as described under “Experimental Proce-
dures” using mutant protein purified by Ni21/NTA and 12CA5 affinity
steps. The substrate was hpr7-labeled at the 59 end with polynucleotide
kinase and hybridized to M13. Products of the reaction were boiled and
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is essential for Dna2-mediated repair of damage due to double-
strand breaks (4), the nuclease defective E640A mutant is
unable to rescue the x-ray repair defect of dna2–2 mutants.
The nuclease active site of Dna2 appears to map to the
N-terminal part of the protein in the RecB homology domain
and can be separated from the ATPase domain, in the sense
that nuclease-inactivating mutations do not appear to diminish
ATPase activity. It has been shown previously that mutations
affecting the ATPase domain lie in the C terminus of the
protein that is also essential for viability. Nevertheless, the
ATPase and helicase activities of the N-terminal mutant,
P504S, are reduced, suggesting that the N terminus and the
C-terminal ATPase domain may somehow interact. This con-
clusion is also supported by the inhibitory effect of ATP on the
nuclease activity in wild type Dna2 and two of the N-terminal
mutants, as well as the ability of ATP to stimulate the nuclease
of the P504S mutant. A summary of the phenotypes of the
mutants and the activities of the mutant proteins studied here
is provided in Table III.
FEN-1 prefers to cleave a 59 tail adjacent to a duplex region
at bases distinct from the single-strand double-strand junction
when the region 59 to the flap structure is single-stranded,
although on other substrates it cleaves at the junction (12, 13).
Our results show that Dna2 shares this specificity, and this
might explain how the two proteins could compensate for each
other in DNA replication and double-strand break repair.
FEN-1, however, does not cut single-stranded oligonucleotides,
whereas Dna2 does cut single-stranded DNA (12, 13, 27). Thus,
Dna2 has both structure-specific activities and simple endonu-
clease activity, whereas FEN-1 is structure-specific. The in vivo
substrates of the two proteins may overlap, since all single-
stranded DNA in the cell is linked to double-stranded DNA.
Although DNA helicase activity is observed with Dna2 ex-
pressed in S. cerevisiae, helicase is weak or unobservable in
baculovirus expressed yeast Dna2 or baculovirus expressed X.
laevis Dna2 (8, 11). Nevertheless, the observation of helicase at
high levels of recombinant protein (11), the absence of DNA
helicase in the K1080E protein (expressed in yeast), as well as
the association of helicase with six other mutant forms of Dna2
(see Figs. 9 and 10B) and under two different purification
regimes continue to suggest that a helicase activity is intrinsic
to Dna2 and not the result of a co-migrating protein that is
removed by the K1080E mutation. Proof of this point will
require finding conditions that restore more efficient helicase
activity to the Dna2 produced in insect cells. Dna2 may require
additional proteins, present only in yeast, for optimal helicase
activity. Given the inhibition of nuclease activity by ATP and by
analogy to RecBC helicase/nuclease, we favor a model in which
there may be an inhibitor of the nuclease associated with Dna2
purified from yeast that allows detection of the helicase. For
RecBC helicase/nuclease, an inhibitor of the nuclease converts
the enzyme from a nuclease into an active helicase. However,
there is no evidence for this with Dna2 as yet.
Another possibility is that Dna2 requires a yeast-specific
modification for helicase activity. G1-specific cyclin-dependent
kinase (28) and Tor1 DNA-dependent protein kinase (3) both
show genetic interactions with Dna2 and therefore are candi-
dates for Dna2 regulators. Yet a third protein kinase, casein
kinase 1, Hrr25, which regulates DNA double-strand break
repair (29, 30), may also modify Dna2, which we have shown
participates in double-strand break repair (5). In S. pombe,
overexpression of Dna2 and Hhp1, a homolog of Hrr25, sup-
presses the temperature-sensitive phenotype of cdc24 (dis-
cussed below) (31).
Role of the Dna2 Helicase/Nuclease in Okazaki Fragment
Metabolism: Direct or Indirect?—DNA synthesized at the re-
strictive temperature in dna2–1 strains is severely fragmented
(2). This and the genetic and physical interactions with FEN-1
originally led us to propose that Dna2 functions in Okazaki
fragment processing (10). To join nascent fragments, the RNA-
containing primer must be removed to prepare for ligation of
DNA into continuous chains. The specificity of the Dna2 enzy-
matic activities can be at least partially reconciled with a role
in primer removal. Dna2 can remove a 59-flap structure, as we
have shown here. Dna2 prefers a single-stranded tail adjacent
to a duplex region and is less active on a substrate with short
stretches of single-stranded DNA flanked by duplex DNA (11).
An unwinding event, however, is required to produce a sub-
strate for the flap endonuclease, be it Dna2 or FEN-1 or one of
the many other endonucleases found in the yeast genome.
Dna2 possesses (or copurifies with) a helicase activity that can
unwind a short segment of duplex DNA (24 nucleotides) at a
forked junction, but Dna2 helicase cannot unwind fully duplex
substrates (2). It is therefore not clear how Dna2 could process
the 59 end of an Okazaki fragment, unless one invokes displace-
ment of the RNA by the oncoming polymerase, as has been
proposed by Murante et al. (27, 32, 33).
Indirect Role for Dna2 in Lagging Strand Events—Several
observations make a direct role in Okazaki fragment process-
ing more difficult to support. The potent single-stranded endo-
nuclease associated with Dna2 would appear to be antagonistic
to lagging strand integrity. Second, rad27Dexo1 mutants and
rad27mre11 mutants are, like rad27Ddna2 mutants, synthet-
ically lethal. Exo1 is a 59 to 39 double-stranded exonuclease that
interacts with Msh2 in two hybrid assays (34, 35). Mrell is also
a nuclease. Thus, either of these might be a backup for rad27.
Overexpression of Exo1 did not suppress the temperature-
sensitive phenotype of dna2–1 mutants and dna2–1exo1 double
mutants are not synthetically lethal.3 If Exo1 processes Oka-
zaki fragments in the absence of FEN-1, then what is the role
of Dna2? We must more seriously examine the idea that Dna2
may play a role, which is essential in every cell cycle, in cor-
recting errors made by FEN-1. Failure of FEN-1 to properly
process Okazaki fragments may lead to broken replication
forks, and the function of Dna2 may involve repairing such
collapsed forks. rad27D rad52D strains are inviable as a likely
consequence of the inability of cells to repair rad27-dependent
errors by recombination (19). Broken replication forks (and
double-strand breaks) are, at least in some cases, repaired by a
mechanism that involves the assembly of new replisomes in an
origin-independent reaction. In bacteria, an enzyme with ac-
tivities similar to Dna2, the PriA 39 to 59 helicase, is involved in
assembling the new primosome (36, 37). This may occur at
collapsed replication forks, where the replisome has disassem-
bled or where double-strand breaks occur as forks encounter
DNA damage. In yeast, DNA polymerase a, primase, and DNA
3 M. E. Budd, W.-C. Choe, and J. L. Campbell, unpublished results.
TABLE III
Summary of phenotypes of dna2 mutants
Complements
dna2–1
Dominant
negative
Repair of
x-ray
damage
ATPase Nuclease Helicase
DNA2 1 2 1 1 1 1
dna2, K1080E 2 2 2 2 1 2
dna2, D657A 2 1 NDb 1 2 1
dna2, E675A 2 1 ND 1 2 1
dna2, Y293A 2 1 ND 1 2 1
dna2, E640A 2 1 2 1 2 1
dna2, P504S 1/2a 2 TSb 1/2 1/2 1/2
a Complements the dna2–1 mutant at 37 °C but only when overpro-
duced.
b ND, not determined.
c Sensitive to x-rays at 30 °C but not at 23 °C.
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polymerase d are also involved in recombinational repair of
double-strand breaks (38). This may also be related to the
break-induced replication described by the latter workers (39).
It is interesting to note that dna2 mutants are sensitive to
agents that cause double-strand breaks, such as x-rays and
bleomycin, and that this sensitivity is suppressed by overpro-
duction of FEN-1 (5). Overproduction of FEN-1 may simply
allow it to function more efficiently, reducing the need for Dna2
on the lagging strand and freeing it for repair of the exog-
enously induced damage. dna2 mutants also have a hyperre-
combination phenotype, suggesting double-strand breaks are
not being efficiently repaired leading to increased recombina-
tion (3). Support for a role for Dna2 in repair of broken repli-
cation forks also is found in other organisms. S. pombe cdc24
has been implicated in repair of collapsed replication forks.
Arrest of cdc24-G1 strains at the restrictive temperature is
followed by loss in viability and chromosome fragmentation (7).
The fragmented chromosomes likely arise from unrepaired bro-
ken replication forks. cdc24 mutants arrest at the restrictive
temperature with 2C DNA content (31). The temperature-sen-
sitive growth defect of cdc24-G1 mutant is suppressed by over-
production of DNA2 (7), which could be allowing repair of the
fragmented chromosomes present in cdc24-G1 cells at 37 °C.
Another allele of cdc24, cdc24-M38, is suppressed by overpro-
duction of proliferating cell nuclear antigen (PCNA) and repli-
cation factor C, establishing a link to the replication apparatus
(31).
Other Helicase/Nucleases Involved in DNA Replication and
Repair—E. coli RecB contains nuclease and helicase encoded in
the same polypeptide (40 for review) and is required for recom-
bination-dependent replication in E. coli and possibly for repair
of DSBs (41). The RecBCD helicase/nuclease is a powerful
helicase that unwinds double-stranded DNA at the rate of 1000
bp/s, creating a single-stranded DNA as a substrate for the
nuclease. In E. coli, broken replication forks can be repaired in
a reaction requiring recA, recBCD, priA, dnaB, dnaG, and Ssb
and the PolIII holoenzyme (reviewed in Ref. 42). The initial
step of repair is catalyzed by RecBCD, which produces a 39
single-stranded tail for invasion of another duplex. In E. coli
inhibition of DNA replication results in significant DNA deg-
radation, which is recB-dependent (43). Strand invasion is ini-
tiated by the helicase activity of RecB when the nuclease is
inactivated after encountering a Chi site in the DNA or induc-
tion of an inhibitor by the SOS response (44). Dna2 may be
involved in such strand invasion. Alternatively, it may be more
like priA and be creating the entry site for the replicative
helicase and the rest of the replisome (41).
The human Werner syndrome protein is also a helicase with
intrinsic nuclease activity (45, 46). The purified protein has a 39
to 59 exonuclease activity and 39 to 59 DNA helicase activity. A
direct involvement in DNA replication is suggested by the
observation that S phase is lengthened in Werner cells (47).
Werner helicase is homologous to S. cerevisiae sgs1 and E. coli
recQ. Sgs1p is a 39 to 59 helicase and probably creates a sub-
strate for Top3, perhaps in termination of DNA replication (48).
Recently, Sgs1 has been shown to be essential for DNA repli-
cation when the srs2 gene, which also encodes a helicase, is also
deleted (49). Both sgs1 and dna2 mutants have hyperrecombi-
nation and chromosomal instability phenotypes. Unlike Dna2,
Sgs1 apparently lacks nuclease activity, and sgs1-ts srs2D mu-
tants fail to synthesize any DNA at the restrictive temperature,
suggesting that Sgs1 and Srs2 helicases are directly involved in
moving the replication fork. In summary, three proteins that
function as a helicase and nuclease, Dna2, RecBCD, and
Werner protein, appear to be required for processing interme-
diates in replication, which can lead to deletions, amplifica-
tions, translocations, and chromosome loss if not resolved.
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